Sort
8,912 grants matching “sars cov 2”
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity
$393,625Calvin J Kuo · Stanford University · R01 · FY2021 · DK
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity
$393,500Calvin J Kuo · Stanford University · R01 · FY2022 · DK
Intestinal organoid modeling of SARS-CoV-2-stimulated innate and adaptive immunity
$393,500Calvin J Kuo · Stanford University · R01 · FY2023 · DK
Regulation of lung inflammatory and antiviral responses during coronavirus infection
$393,437Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
Addressing community-level influences of HIV and COVID-19 disparities among people with HIV
$393,365Diana Montserrat Sheehan · Florida International University · U54 · FY2023 · MD
Deep learning-based serological test for point-of-care analysis of COVID-19 immunity with a paper-based multiplexed sensor
$393,222Aydogan Ozcan · University Of California-Los Angeles · · FY2022 · ENG
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)
$393,065John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms for post-COVID pituitary damage
$392,800Takako Araki · University Of Minnesota · R01 · FY2022 · DK
A Phase II Study Evaluating Fostamatinib for Hospitalized Adults with COVID-19.
$392,743Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Mucosal B-cell aging in PLWH
$392,709Marta Epeldegui · University Of California Los Angeles · R56 · FY2024 · AG
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
$392,655Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2021 · AI
Mammal-virus evolution from global to local scales
$392,500Nathan Steadman Upham · Arizona State University-Tempe Campus · R35 · FY2025 · GM
Epidemiology and Genetics of Susceptibility to COVID-19 Infection
$392,042Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Indentification and characterization of cellular receptors for enveloped viruses
$391,900Michael R. Farzan · Harvard Medical School · U54 · FY2009 · AI
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2024 · DA
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2023 · DA
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2025 · DA
Mechanisms for post-COVID pituitary damage
$391,475Takako Araki · University Of Minnesota · R01 · FY2023 · DK
Investigating fibrinogen as a pathologic and targetable mediator of COVID-19-associated coagulopathy
$391,250Cheryl Maier · Emory University · R00 · FY2025 · HL
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
$391,250Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Restoring immune-vascular axis integrity to alleviate acute lung injury in sepsis
$391,250Krishnendu Pal · Mayo Clinic Jacksonville · R56 · FY2022 · HL
Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck
$390,906Joshua Labaer · Arizona State University-Tempe Campus · R33 · FY2023 · CA
Virus-Like Particle Vaccine for SARS-CoV
$390,546Raphael Paul Viscidi · Johns Hopkins University · R01 · FY2009 · AI
Virus-Like Particle Vaccine for SARS-CoV
$390,546Raphael Paul Viscidi · Johns Hopkins University · R01 · FY2008 · AI
Targeting a Human Acyltransferase for Broad-Spectrum Antivirals
$390,500Robert G Lowery · Bellbrook Labs, Llc · R21 · FY2021 · AI